- Home
- VIR vs LEGH Comparison
VIR vs LEGH Comparison
Compare VIR & LEGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- LEGH
- Stock Information
- Founded
- VIR 2016
- LEGH 2005
- Country
- VIR United States
- LEGH United States
- Employees
- VIR N/A
- LEGH N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- LEGH Homebuilding
- Sector
- VIR Health Care
- LEGH Consumer Discretionary
- Exchange
- VIR Nasdaq
- LEGH Nasdaq
- Market Cap
- VIR 706.4M
- LEGH 588.8M
- IPO Year
- VIR 2019
- LEGH 2018
- Fundamental
- Price
- VIR $5.65
- LEGH $22.75
- Analyst Decision
- VIR Strong Buy
- LEGH Strong Buy
- Analyst Count
- VIR 8
- LEGH 2
- Target Price
- VIR $30.25
- LEGH $29.00
- AVG Volume (30 Days)
- VIR 1.2M
- LEGH 80.5K
- Earning Date
- VIR 08-04-2025
- LEGH 08-07-2025
- Dividend Yield
- VIR N/A
- LEGH N/A
- EPS Growth
- VIR N/A
- LEGH 8.04
- EPS
- VIR N/A
- LEGH 2.29
- Revenue
- VIR $20,861,000.00
- LEGH $176,618,000.00
- Revenue This Year
- VIR N/A
- LEGH N/A
- Revenue Next Year
- VIR $0.62
- LEGH $7.69
- P/E Ratio
- VIR N/A
- LEGH $9.93
- Revenue Growth
- VIR N/A
- LEGH N/A
- 52 Week Low
- VIR $4.32
- LEGH $21.58
- 52 Week High
- VIR $14.45
- LEGH $29.31
- Technical
- Relative Strength Index (RSI)
- VIR 54.74
- LEGH 49.32
- Support Level
- VIR $5.31
- LEGH $22.32
- Resistance Level
- VIR $5.92
- LEGH $23.32
- Average True Range (ATR)
- VIR 0.30
- LEGH 0.60
- MACD
- VIR 0.02
- LEGH -0.05
- Stochastic Oscillator
- VIR 43.69
- LEGH 39.33
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About LEGH Legacy Housing Corporation (TX)
Legacy Housing Corp builds, sell, and finance manufactured homes and tiny houses that are distributed through a network of independent retailers and company-owned stores and also sold directly to manufactured home communities. The company also provides financing options to its customers to facilitate the sale of homes.